-
Super-Enhancer Regulation of SLC7A11 Drives Disulfidptosis i
2026-07-17
This study uncovers a novel regulatory axis in prostate cancer, where super-enhancers drive SLC7A11 expression via FOXA1, promoting disulfidptosis under glucose deprivation. The findings highlight actionable epigenetic targets and provide a mechanistic basis for future therapeutic interventions in castration-resistant prostate cancer.
-
Baicalin Methyl Ester Protects Intestinal Barrier via P65/TN
2026-07-16
The referenced study reveals that baicalin methyl ester (BME) attenuates LPS-induced intestinal barrier damage in mice by modulating the P65/TNF-α/MLCK/ZO-1 signaling pathway. These findings highlight BME's potential as a molecular tool for dissecting tight junction regulation and inflammatory injury in intestinal models.
-
WEHI-539: Dissecting BCL-XL Dependency in Apoptosis and Canc
2026-07-16
Explore how WEHI-539, a potent BCL-XL inhibitor, advances our understanding of apoptosis and cancer stem cell sensitization. This article uniquely bridges mechanistic insights with experimental strategy, revealing practical decisions in targeting BCL-XL for overcoming chemoresistance.
-
0.4% Trypan Blue Solution: Practical Guide for Cell Viabilit
2026-07-15
0.4% Trypan Blue Solution (SKU K1183) is a validated azo dye for cell staining, enabling clear live/dead cell discrimination during cell viability measurement and cell counting. This reagent is suited for research workflows requiring reliable assessment of viable and non-viable cells, especially in cell culture and cytotoxicity assays. It is not intended for diagnostic or clinical applications, and results may not be suitable for regulatory submissions.
-
Oligo (dT) 25 Beads: Optimized mRNA Isolation Protocols
2026-07-15
Oligo (dT) 25 Beads enable targeted, high-yield purification of eukaryotic mRNA from animal or plant cells by capturing polyA-tailed transcripts. This product is best suited for workflows requiring intact mRNA for downstream applications like cDNA synthesis or RT-PCR. It is not intended for prokaryotic RNA isolation or samples lacking polyadenylated mRNA.
-
Alternariol-Induced Hepatic Stellate Cell Fibrosis: Omics In
2026-07-14
This study employs lncRNA-mRNA omics to reveal how Alternariol (AOH), a prevalent foodborne mycotoxin, drives hepatic stellate cell (HSC) transdifferentiation into myofibroblasts, a key event in liver fibrosis. The work clarifies the molecular pathways underlying AOH-induced hepatotoxicity and proposes a laccase-based detoxification strategy, informing both food safety monitoring and liver disease research.
-
Alternariol in Mycotoxin Research: Protocols and Troubleshoo
2026-07-14
Alternariol (AOH) is a pivotal tool in mycotoxin and hepatotoxicity research, offering reproducible workflows for dissecting apoptosis, cytochrome P450 metabolism, and hepatic fibrosis. This article details experimental strategies, optimization tips, and the newest omics-driven insights that differentiate AOH-powered assays for toxin mechanism studies.
-
High-Throughput Quantification of Drug-Induced Fractional Ki
2026-07-13
Inde et al. (2021) introduce a robust protocol for quantifying drug-induced fractional killing in cancer cell populations using high-throughput microscopy. This method enables systematic comparison of cell death responses across hundreds of conditions, enhancing the rigor and scalability of apoptosis and kinase inhibitor studies.
-
Applied Advances with Annexin V-APC/7-AAD Apoptosis Kit
2026-07-13
The Annexin V-APC/7-AAD Apoptosis Kit from APExBIO empowers researchers to rapidly distinguish apoptotic from necrotic cells in complex experimental models, streamlining cell death analysis with dual-color precision. This article unpacks protocol enhancements, troubleshooting, and unique assay applications—including insights drawn from recent tumor microenvironment research.
-
Cytarabine (AraC): Precision Tools for Apoptosis Pathways Re
2026-07-12
Explore how Cytarabine (AraC) uniquely enables precise, mechanism-based interrogation of apoptosis and DNA damage pathways in leukemia research. This article delivers advanced insights into p53-mediated responses and necroptosis cross-talk, setting it apart from conventional workflow guides.
-
Exosomal Egr2 Regulates RNF8/DAPK1 Axis in Ischemic Stroke
2026-07-10
This study reveals that bone marrow-derived mesenchymal stem cell (BMSC) exosomes containing Egr2 reduce neuronal injury following ischemic stroke via the RNF8/DAPK1 axis. The findings elucidate a novel molecular mechanism underlying neuroprotection in oxygen-glucose deprivation/reoxygenation (OGD/R) models, with implications for targeted therapeutic strategies.
-
Cell Cycle Assay Kit (K2263): Precision in Cell Cycle Analys
2026-07-09
The Cell Cycle Assay Kit enables precise identification of cell cycle phases G0/G1, S, and G2/M through propidium iodide staining and flow cytometry. This kit supports robust cell cycle progression analysis and apoptosis detection, making it a valuable tool for cancer research and cell biology applications.
-
Staurosporine: Broad-Spectrum Kinase Inhibitor in Cancer Res
2026-07-09
Staurosporine stands at the forefront of kinase research as a broad-spectrum serine/threonine protein kinase inhibitor, offering unmatched versatility for apoptosis induction and signaling pathway analysis. Leveraging high-throughput microscopy, scientists can now quantify drug-induced fractional killing with unprecedented precision and reproducibility.
-
Biomimetic Nanoparticles Mitigate Ovarian Inflammation via N
2026-07-08
This study introduces a targeted nanoparticle system delivering α-cyperone to granulosa cells, significantly reducing inflammation and oxidative stress in a cellular model of diminished ovarian reserve. The findings highlight a dual mechanism—activation of Nrf2/HO-1 and suppression of ROS—potentially paving the way for novel interventions in reproductive aging.
-
HDAC Inhibition Targets Epigenetic Pathways in MLL-ALL
2026-07-08
This study demonstrates that panobinostat, a broad-spectrum HDAC inhibitor, exerts strong in vivo anti-leukaemic effects against MLL-rearranged acute lymphoblastic leukaemia by targeting the RNF20/RNF40/WAC-H2B ubiquitination axis. The findings highlight the therapeutic potential of epigenetic pathway modulation in overcoming chemoresistance in aggressive infant ALL.